Stockscreener 앱 받기
3.32
5.14%
-0.18
Oramed Pharmaceuticals Inc 주식(ORMP)의 최신 뉴스
Oramed Pharmaceuticals: Oral Insulin Technology, Strategic Investments, and 2026 Business Overview - Minichart
Oramed: Q4 Earnings Snapshot - 10TV
Oramed Pharmaceuticals 2025 10-K: $2.0M Revenue, $1.50 Diluted EPS - TradingView
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward Successfully Closes on Strategic Partnership with Oramed - GlobeNewswire
Lifeward Ltd. completed the acquisition of Oratech Pharma, Inc. from Oramed Pharmaceuticals Inc.. - marketscreener.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Oramed Pharmaceuticals Inc expected to post breakeven results a shareEarnings Preview - TradingView
Surprises Report: Does Oramed Pharmaceuticals Inc stock benefit from AI growth2026 Macro Impact & Pattern Based Trade Signal System - baoquankhu1.vn
Oramed Pharmaceuticals (ORMP) to Release Earnings on Thursday - MarketBeat
Market Overview: What is Oramed Pharmaceuticals Incs 5 year growth outlookEarnings Growth Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
[Form 4] ORAMED PHARMACEUTICALS INC. Insider Trading Activity - Stock Titan
Oramed (NASDAQ: ORMP) CEO receives 167,005 RSUs vesting from 2026 - Stock Titan
Oramed (NASDAQ: ORMP) COO receives 95,889 RSUs vesting from 2026 - Stock Titan
Oramed (NASDAQ: ORMP) CFO receives 95,889 RSU equity award - Stock Titan
Oramed deal reshapes Lifeward (NASDAQ: LFWD) with new tech and funding - Stock Titan
Oral insulin and robotic exoskeletons: Lifeward’s $47M pivot - Stock Titan
Retail Trends: How sensitive is Oramed Pharmaceuticals Inc to inflationWeekly Trade Recap & Low Risk Entry Point Guides - baoquankhu1.vn
Is Oramed Pharmaceuticals Inc stock undervalued right nowEarnings Risk Report & Verified Momentum Watchlists - baoquankhu1.vn
Returns Recap: Is Oramed Pharmaceuticals Inc stock a smart retirement pickMarket Volume Report & High Yield Stock Recommendations - baoquankhu1.vn
Oramed (ORMP) CEO donates 100,000 shares to charity - Stock Titan
Lifeward shareholders approve Oramed partnership deal By Investing.com - Investing.com India
Lifeward shareholders approve Oramed partnership deal - Investing.com
Lifeward Partners with Oramed to Enhance Biotech Portfolio and Drive Path to Profitability - Quiver Quantitative
Shareholders back Lifeward–Oramed bet on insulin pills and $47M war chest - Stock Titan
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed-Creating Diversified Biomedical Company - Bitget
LFWD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Gains Report: What is the target price for Oramed Pharmaceuticals Inc stockChart Signals & Consistent Return Investment Signals - baoquankhu1.vn
Aug PreEarnings: What is Oramed Pharmaceuticals Incs 5 year growth outlookWeekly Profit Recap & Expert Curated Trade Setups - baoquankhu1.vn
Oramed Pharmaceuticals (ORMP) Leads Healthcare Dividend Yields - GuruFocus
Top 10 healthcare stocks with highest dividend yield amid volatile markets (ORMP:NASDAQ) - Seeking Alpha
DYCQ Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Dip Buying: Is Oramed Pharmaceuticals Inc stock a smart retirement pick2025 Growth vs Value & Safe Entry Trade Signal Reports - baoquankhu1.vn
Update Report: Can Oramed Pharmaceuticals Inc maintain sales growthShare Buyback & Accurate Buy Signal Alerts - baoquankhu1.vn
ORMP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Short Interest in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Declines By 16.2% - MarketBeat
ORMP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ORMP Technical Analysis & Stock Price Forecast - Intellectia AI
Guidance Update: Should you avoid Oramed Pharmaceuticals Inc stock right nowJuly 2025 Breakouts & Low Drawdown Investment Strategies - baoquankhu1.vn
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Above 50 Day Moving AverageHere's Why - MarketBeat
Scilex Grants Oramed New Warrant in Financing Agreement - The Globe and Mail
Is Oramed Pharmaceuticals Inc. stock overvalued or fairly priced2025 Earnings Impact & Weekly Stock Breakout Alerts - mfd.ru
Oramed Pharmaceuticals Restructures Scilex Notes via Warrant Deal - TipRanks
Oramed (NASDAQ: ORMP) gains Scilex stock warrant through new agreement - Stock Titan
What is the target price for Oramed Pharmaceuticals Inc. stockEarnings Risk Report & Low Risk High Win Rate Stock Picks - mfd.ru
Is Oramed Pharmaceuticals Inc. stock a smart retirement pickJuly 2025 Trade Ideas & AI Driven Price Predictions - mfd.ru
ORMP PE Ratio & Valuation, Is ORMP Overvalued - Intellectia AI
What are analysts’ price targets for Oramed Pharmaceuticals Inc.Quarterly Earnings Summary & Daily Entry Point Trade Alerts - mfd.ru
Oramed boosts Nano Dimension (NNDM) holding to 5.2% and signals engagement - Stock Titan
Will Oramed Pharmaceuticals Inc. (OJU1) stock recover faster than industryJuly 2025 Gainers & Precise Swing Trade Entry Alerts - mfd.ru
Aug Setups: What drives Oramed Pharmaceuticals Inc.’s stock priceJuly 2025 Outlook & Safe Entry Point Identification - mfd.ru
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Up 57.8% in January - MarketBeat
ORMP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Geopolitics Watch: Can Oramed Pharmaceuticals Inc keep up with sector leaders2025 Earnings Surprises & Weekly Top Gainers Trade List - baoquankhu1.vn
Is Oramed Pharmaceuticals Inc. stock undervalued right nowMarket Volume Summary & AI Powered Market Trend Analysis - mfd.ru
Support Test: Should you avoid Oramed Pharmaceuticals Inc stock right now2025 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
0.04%
0.06%
자본화:
|
볼륨(24시간):